Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration
Status:
Terminated
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of an ocular sirolimus
(rapamycin) formulation via different injection routes in patients with treatment-naive
sub-foveal choroidal neovascularization secondary to age-related macular degeneration.